For millions of Americans who buy their own health insurance through the Affordable Care Act marketplace, the end of the year brings a day of reckoning: It’s time to compare benefits and prices and change to a new plan or enroll for the first time.
Numinus Cedar Clinical Research Selected as Site for Cybin’s Phase 3 Study of CYB003, disclosure
The TDR Three Key Takeaways for Numinus and Cybin’s Phase 3 Study of CYB003: Numinus being selected by Cybin to conduct research trials validates its